China Endothelin Receptor Antagonist Market Research Report Forecast 2017 to 2022

December 2017 | 133 pages | ID: C7378282412EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The China Endothelin Receptor Antagonist Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Endothelin Receptor Antagonist industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Endothelin Receptor Antagonist market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.

China Endothelin Receptor Antagonist Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Endothelin Receptor Antagonist Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 ENDOTHELIN RECEPTOR ANTAGONIST MARKET OVERVIEW

1.1 Product Overview and Scope of Endothelin Receptor Antagonist
1.2 Endothelin Receptor Antagonist Market Segmentation by Type
  1.2.1 China Production Market Share of Endothelin Receptor Antagonist by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Endothelin Receptor Antagonist Market Segmentation by Application
  1.3.1 Endothelin Receptor Antagonist Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Endothelin Receptor Antagonist (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON ENDOTHELIN RECEPTOR ANTAGONIST INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Endothelin Receptor Antagonist Industry

CHAPTER 3 CHINA ENDOTHELIN RECEPTOR ANTAGONIST MARKET COMPETITION BY MANUFACTURERS

3.1 China Endothelin Receptor Antagonist Production and Share by Manufacturers (2015 and 2016)
3.2 China Endothelin Receptor Antagonist Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Endothelin Receptor Antagonist Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Endothelin Receptor Antagonist Manufacturing Base Distribution, Production Area and Product Type
3.5 Endothelin Receptor Antagonist Market Competitive Situation and Trends
  3.5.1 Endothelin Receptor Antagonist Market Concentration Rate
  3.5.2 Endothelin Receptor Antagonist Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA ENDOTHELIN RECEPTOR ANTAGONIST CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Endothelin Receptor Antagonist Capacity, Production and Growth (2012-2017)
4.2 China Endothelin Receptor Antagonist Revenue and Growth (2012-2017)
4.3 China Endothelin Receptor Antagonist Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA ENDOTHELIN RECEPTOR ANTAGONIST PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Endothelin Receptor Antagonist Production and Market Share by Type (2012-2017)
5.2 China Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
5.3 China Endothelin Receptor Antagonist Price by Type (2012-2017)
5.4 China Endothelin Receptor Antagonist Production Growth by Type (2012-2017)

CHAPTER 6 CHINA ENDOTHELIN RECEPTOR ANTAGONIST MARKET ANALYSIS BY APPLICATION

6.1 China Endothelin Receptor Antagonist Consumption and Market Share by Application (2012-2017)
6.2 China Endothelin Receptor Antagonist Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURERS ANALYSIS

7.1 Actelion Pharmaceuticals Ltd.
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 United Therapeutics Corporation
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Gilead sciences
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Bayer AG
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 SteadyMed Ltd.
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 GlaxoSmithKline plc
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Pfizer Inc.
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Reata Pharmaceuticals Inc.
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Arena Pharmaceuticals Inc.
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURING COST ANALYSIS

8.1 Endothelin Receptor Antagonist Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Endothelin Receptor Antagonist

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Endothelin Receptor Antagonist Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA ENDOTHELIN RECEPTOR ANTAGONIST MARKET FORECAST (2017-2022)

12.1 China Endothelin Receptor Antagonist Production, Revenue Forecast (2017-2022)
12.2 China Endothelin Receptor Antagonist Production, Consumption Forecast by Regions (2017-2022)
12.3 China Endothelin Receptor Antagonist Production Forecast by Type (2017-2022)
12.4 China Endothelin Receptor Antagonist Consumption Forecast by Application (2017-2022)
12.5 Endothelin Receptor Antagonist Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Endothelin Receptor Antagonist
Figure China Production Market Share of Endothelin Receptor Antagonist by Type in 2016
Table Endothelin Receptor Antagonist Consumption Market Share by Application in 2016
Figure China Endothelin Receptor Antagonist Revenue (Million USD) and Growth Rate (2012-2021)
Table China Endothelin Receptor Antagonist Capacity of Key Manufacturers (2015 and 2016)
Table China Endothelin Receptor Antagonist Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Endothelin Receptor Antagonist Capacity of Key Manufacturers in 2015
Figure China Endothelin Receptor Antagonist Capacity of Key Manufacturers in 2016
Table China Endothelin Receptor Antagonist Production of Key Manufacturers (2015 and 2016)
Table China Endothelin Receptor Antagonist Production Share by Manufacturers (2015 and 2016)
Figure 2015 Endothelin Receptor Antagonist Production Share by Manufacturers
Figure 2016 Endothelin Receptor Antagonist Production Share by Manufacturers
Table China Endothelin Receptor Antagonist Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Endothelin Receptor Antagonist Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table 2016 China Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table China Market Endothelin Receptor Antagonist Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Endothelin Receptor Antagonist Average Price of Key Manufacturers in 2016
Table Manufacturers Endothelin Receptor Antagonist Manufacturing Base Distribution and Sales Area
Table Manufacturers Endothelin Receptor Antagonist Product Type
Figure Endothelin Receptor Antagonist Market Share of Top 3 Manufacturers
Figure Endothelin Receptor Antagonist Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Endothelin Receptor Antagonist Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Endothelin Receptor Antagonist Market Share (2012-2017)
Table Actelion Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table United Therapeutics Corporation Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Endothelin Receptor Antagonist Market Share (2012-2017)
Table Gilead sciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Gilead sciences Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Gilead sciences Endothelin Receptor Antagonist Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Endothelin Receptor Antagonist Market Share (2012-2017)
Table SteadyMed Ltd. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SteadyMed Ltd. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table SteadyMed Ltd. Endothelin Receptor Antagonist Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Market Share (2012-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. Endothelin Receptor Antagonist Market Share (2012-2017)
Table Reata Pharmaceuticals Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Market Share (2012-2017)
Table Arena Pharmaceuticals Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Production, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Market Share (2012-2017)
Figure Production Revenue Share of Endothelin Receptor Antagonist by Type (2012-2017)
Figure 2015 Revenue Market Share of Endothelin Receptor Antagonist by Type
Table China Endothelin Receptor Antagonist Price by Type (2012-2017)
Figure China Endothelin Receptor Antagonist Production Growth by Type (2012-2017)
Table China Endothelin Receptor Antagonist Consumption by Application (2012-2017)
Table China Endothelin Receptor Antagonist Consumption Market Share by Application (2012-2017)
Figure China Endothelin Receptor Antagonist Consumption Market Share by Application in 2016
Table China Endothelin Receptor Antagonist Consumption Growth Rate by Application (2012-2017)
Figure China Endothelin Receptor Antagonist Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endothelin Receptor Antagonist
Figure Manufacturing Process Analysis of Endothelin Receptor Antagonist
Figure Endothelin Receptor Antagonist Industrial Chain Analysis
Table Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2015
Table Major Buyers of Endothelin Receptor Antagonist
Table Distributors/Traders List
Figure China Endothelin Receptor Antagonist Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Table China Endothelin Receptor Antagonist Production, Import, Export and Consumption Forecast (2017-2022)
Table China Endothelin Receptor Antagonist Production Forecast by Type (2017-2022)
Table China Endothelin Receptor Antagonist Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
Merck & Co. Inc